<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tsoucalas, G.</style></author><author><style face="normal" font="default" size="100%">Chevallier, J.</style></author><author><style face="normal" font="default" size="100%">Karamanou, M.</style></author><author><style face="normal" font="default" size="100%">Papaioannou, T.</style></author><author><style face="normal" font="default" size="100%">Sgantzos, M.</style></author><author><style face="normal" font="default" size="100%">Androutsos, G.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Historical hallmarks of anticoagulation and antiplatelet agents</style></title><secondary-title><style face="normal" font="default" size="100%">Current Pharmaceutical Design</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2016</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964240547&amp;partnerID=40&amp;md5=57ad48a5b1ff3297fa883eb47b2b88b6</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">22</style></volume><pages><style face="normal" font="default" size="100%">1857 - 1861</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">13</style></issue><notes><style face="normal" font="default" size="100%">Cited By :1Export Date: 22 March 2017</style></notes></record></records></xml>